Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks

This randomized clinical trial extension evaluates efficacy and safety outcomes of avalglucosidase alfa treatment in patients with late-onset Pompe disease.
Source: JAMA Neurology - Category: Neurology Source Type: research